EA200802421A1 - METHOD OF TREATMENT ENDOMETRIOSIS - Google Patents
METHOD OF TREATMENT ENDOMETRIOSISInfo
- Publication number
- EA200802421A1 EA200802421A1 EA200802421A EA200802421A EA200802421A1 EA 200802421 A1 EA200802421 A1 EA 200802421A1 EA 200802421 A EA200802421 A EA 200802421A EA 200802421 A EA200802421 A EA 200802421A EA 200802421 A1 EA200802421 A1 EA 200802421A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- drug
- endometriosis
- course
- treatment endometriosis
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Изобретение относится к медицине, в частности, к лечению эндометриоза. Согласно способа лечения эндометриоза в течении курса лечения пациентке вводят лекарственный препарат, причем в качестве препарата используют гликопротеин, выделенный из фолликулярной жидкости крупного рогатого скота, причем в процессе курса лечения данный препарат вводят в дозе 150-600 мг, а курс лечения составляет 10-30 инъекций препарата в зависимости от степени выраженности эндометриоза.The invention relates to medicine, in particular, to the treatment of endometriosis. According to the method of treating endometriosis during the course of treatment, the patient is injected with a drug, and a glycoprotein isolated from the follicular liquid of cattle is used as a drug, and during the course of treatment this drug is administered in a dose of 150-600 mg, and the course of treatment is 10-30 injections of the drug, depending on the severity of endometriosis.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2008101585/14A RU2359684C1 (en) | 2008-01-23 | 2008-01-23 | Way of endometriosis treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200802421A1 true EA200802421A1 (en) | 2009-08-28 |
EA016009B1 EA016009B1 (en) | 2012-01-30 |
Family
ID=41027084
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200802421A EA016009B1 (en) | 2008-01-23 | 2008-12-17 | Method for treating endometriosis |
Country Status (2)
Country | Link |
---|---|
EA (1) | EA016009B1 (en) |
RU (1) | RU2359684C1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2732251C1 (en) * | 2019-11-29 | 2020-09-14 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" | Method of treating external genital endometriosis |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5681817A (en) * | 1994-02-04 | 1997-10-28 | The Medical College Of Hampton Roads | Treatment of ovarian estrogen dependent conditions |
RU2201241C2 (en) * | 2001-06-06 | 2003-03-27 | Закрытое акционерное общество "СКАЙ ЛТД" | Method of purification of protein of family of growth transforming factors prepared from follicular fluid |
FR2827290B1 (en) * | 2001-07-13 | 2004-07-09 | Pierre Jouan Biotechnologies Sa | METHOD FOR OBTAINING A PROTEIN FRACTION ENRICHED IN ACTIVATED FORM TGF-BETA, PROTEIN FRACTION AND THERAPEUTIC APPLICATIONS |
-
2008
- 2008-01-23 RU RU2008101585/14A patent/RU2359684C1/en not_active IP Right Cessation
- 2008-12-17 EA EA200802421A patent/EA016009B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EA016009B1 (en) | 2012-01-30 |
RU2359684C1 (en) | 2009-06-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008039898A3 (en) | Methods for the treatment of a traumatic central nervous system injury | |
CY1113253T1 (en) | Dosage regimen for therapeutic treatment of a traumatic brain injury with progesterone | |
MX2013004406A (en) | Treating diabetes melitus using insulin injections administered with varying injection intervals. | |
EA201590902A1 (en) | METHODS AND DEVICES APPLICABLE FOR THE TREATMENT OF EYE DISEASES IN HUMAN | |
BRPI0518460A2 (en) | Method for treating an allergic emergency in a patient, drug delivery device containing an epinephrine solution, and kit for treating an allergic emergency ' | |
NZ599558A (en) | Dosing regimen associated with long-acting injectable paliperidone esters | |
RU2008138381A (en) | ADRENALINE DOSAGE MODES | |
MX2019007779A (en) | Method of treating or reducing efp. | |
MX2018013715A (en) | Aqueous based capsaicinoid formulations, and treatment in combination with a corticosteroid. | |
NZ744233A (en) | Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack | |
BR112015004110A2 (en) | prostate drug delivery systems and methods | |
BR112015003836A2 (en) | drug delivery systems and methods for bladder cancer treatment | |
MX2016006179A (en) | Aqueous based capsaicinoid formulations and methods of manufacture and use. | |
Behdad et al. | Effect of gabapentin on postoperative pain and operation complications: a randomized placebo controlled trial. | |
AR088204A1 (en) | MEDICINES FOR THE TREATMENT OF ALLERGY RHINITIS THAT INCLUDE A PGD2 ANTAGONIST AND A HISTAMINE ANTAGONIST | |
JP2014530246A5 (en) | ||
WO2007100590A3 (en) | Methods for treating cellulite | |
EA200802421A1 (en) | METHOD OF TREATMENT ENDOMETRIOSIS | |
BR112013010345A2 (en) | diabetes mellitus treatment using insulin injections administered at varying injection intervals | |
Loo | Is ketamine ready to be used clinically for the treatment of depression | |
EA200801388A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF TUBERCULOSIS AND DISEASES MEDIATED BY HELICOBACTER PILORY BASED ON POLYMERIC NANOPARTICLES, ITS TREATMENT METHOD AND TREATMENT METHOD | |
Kavandi | Interferon-α-2a | |
RU2007120403A (en) | METHOD FOR LOCAL THERAPY OF AUTOIMMUNE ARTHRITIS | |
Mota | Esomeprazole/pantoprazole | |
Brodell | Subcutaneous lipoatrophy treated with polylactic acid: case report |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ KG MD TJ TM |